Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-9,989
Closed -$252K 625
2023
Q1
$252K Buy
+9,989
New +$248K 0.01% 465
2022
Q4
Sell
-12,746
Closed -$322K 692
2022
Q3
$322K Buy
12,746
+3,251
+34% +$95.7K 0.01% 377
2022
Q2
$289K Buy
9,495
+3,148
+50% +$112K 0.01% 437
2022
Q1
$223K Buy
+6,347
New +$226K 0.01% 514
2020
Q3
Sell
-971
Closed -$24K 664
2020
Q2
$24K Buy
+971
New +$23.1K ﹤0.01% 357
2019
Q4
Sell
-1,170
Closed -$26K 709
2019
Q3
$26K Sell
1,170
-106
-8% -$2.37K ﹤0.01% 207
2019
Q2
$32K Buy
1,276
+106
+9% +$2.52K ﹤0.01% 155
2019
Q1
$25K Buy
+1,170
New +$26.3K ﹤0.01% 183
2018
Q4
Sell
-244
Closed -$6K 465
2018
Q3
$6K Buy
+244
New +$6.24K ﹤0.01% 311

Other funds holding PHI

Balentine LLC's PHI Position: Q2 2023 in Review

Balentine LLC sold out of PLDT (PHI) in Q2 2023, closing a stake of 9,989 shares — an estimated $252K sold.

Balentine LLC first reported a position in PHI in Q3 2018 and held it in 9 quarters. The position peaked at $322K in Q3 2022. 63 funds tracked by Wall St. Rank hold PHI as of Q2 2023.

  • Balentine LLC reported no remaining PLDT position as of Q2 2023 after selling out during the quarter.
  • Balentine LLC sold 9,989 PLDT shares in Q2 2023, an estimated $252K.
  • Balentine LLC first reported a position in PLDT in Q3 2018 and held it in 9 quarters.
  • Balentine LLC's PLDT position peaked at $322K in Q3 2022.
  • 63 funds tracked by Wall St. Rank held PLDT as of Q2 2023.

Based on Balentine LLC's 13F filing for Q2 2023, filed 14 Aug 2023.